التفاصيل البيبلوغرافية
| العنوان: |
Bortezomib is active in patients with untreated or relapsed Waldenstrom's macroglobulinemia: a phase II study of the National Cancer Institute of Canada Clinical Trials Group. |
| المؤلفون: |
Chen CI, Kouroukis CT, White D, Voralia M, Stadtmauer E, Stewart AK, Wright JJ, Powers J, Walsh W, Eisenhauer E, National Cancer Institute of Canada Clinical Trials Group |
| المصدر: |
Journal of Clinical Oncology; 4/20/2007, Vol. 25 Issue 12, p1570-1575, 6p |
| قاعدة البيانات: |
Supplemental Index |
